Menu Close
The Conversation

John Field

1

Article

0

Comments
Professor in Molecular and Clinical Cancer Medicine, University of Liverpool

Professor John Field, PhD, FRCPath has a Personal Clinical Chair in Molecular Oncology at the University of Liverpool. He is a Visiting Professor at University College London, holds the post of Director of Research of the Roy Castle Lung Cancer Research Programme. He is the CI for the UK Lung Cancer Screening Trial (UKLS), Chair of the EU-US Spiral CT collaborative group, Chair (2011- ) IASLC Early Detection and Prevention Committee. He was presented with the IASLC Joseph Cullen Award at the WCLC 2011, in recognition of lifetime scientific achievements in lung cancer prevention research. He is Chair of the IASLC Strategic Screening Advisory Committee.

He is the principle investigator of the Liverpool Lung Project, a molecular- epidemiological study into the early detection of lung cancer, funded by the Roy Castle Lung Cancer Foundation. He is also PI on the large EU Early Lung Cancer study funded by the Commission. Both of these trials form part of the NCRI Lung Cancer clinical studies group’s portfolio. Currently, a Partner in the FP7 CURELUNG and LCAOS projects. He is also heavily involved in the identification of molecular diagnostic markers in lung and head & neck cancer and has led the team searching for the familial oesophageal cancer gene (TOC) over the past decade, His research funding has been provided mainly by the RCF, NWCRF, MRC, CRUK, EU and HTA .

Professor Field is the author of over 225 international (peer reviewed) papers in his area of expertise and has given more than 270 presentations at medical and scientific conferences around the world.

Experience

  • –present
    Professor in Molecular and Clinical Cancer Medicine, University of Liverpool

Publications

  • 2013
    Lancet Oncology, CT screening for lung cancer: countdown to implementation. Field JK, Hansell DM, Duffy SW, Baldwin DR. Lancet Oncol. 2013 Dec;14(13):e591-600. doi: 10.1016/S1470-2045(13)70293-6.
  • 2013
    Lancet, Prospects for population screening and diagnosis of lung cancer. Field JK, Oudkerk M, Pedersen JH, Duffy SW. Lancet. 2013 Aug 24;382(9893):732-41. doi: 10.1016/S0140-6736(13)61614-1.
  • 2013
    Sci. Transl. Med, A prognostic DNA methylation signature for stage I non-small-cell lung cancer. Sandoval J, Mendez-Gonzalez J, Nadal E, Chen G, Carmona FJ, Sayols S, Moran S, Heyn H, Vizoso M, Gomez A, Sanchez-Cespedes M, Assenov Y, Müller F, Bock C, Taron M, Mora J, Muscarella LA, Liloglou T, Davies M, Pollan M, Pajares MJ, Torre W, Montuenga LM, Brambilla E, Field JK, Roz L, Lo Iacono M, Scagliotti GV, Rosell R, Beer DG, Esteller M. J Clin Oncol. 2013 Nov 10;31(32):4140-7. doi: 10.1200/JCO.2012.48.5516. Epub 2013 Sep 30.
  • 2013
    J Clin Oncol, A prognostic DNA methylation signature for stage I non-small-cell lung cancer. Sandoval J, Mendez-Gonzalez J, Nadal E, Chen G, Carmona FJ, Sayols S, Moran S, Heyn H, Vizoso M, Gomez A, Sanchez-Cespedes M, Assenov Y, Müller F, Bock C, Taron M, Mora J, Muscarella LA, Liloglou T, Davies M, Pollan M, Pajares MJ, Torre W, Montuenga LM, Brambilla E, Field JK, Roz L, Lo Iacono M, Scagliotti GV, Rosell R, Beer DG, Esteller M. J Clin Oncol. 2013 Nov 10;31(32):4140-7. doi: 10.1200/JCO.2012.48.5516. Epub 2013 Sep 30.
  • 2013
    J Surg Oncol, European randomized lung cancer screening trials: Post NLST. Field JK, van Klaveren R, Pedersen JH, Pastorino U, Paci E, Becker N, Infante M, Oudkerk M, de Koning HJ; on behalf of the European Randomized Screening Trial Group. J Surg Oncol. 2013 Jul 25. doi: 10.1002/jso.23383. [Epub ahead of print]
  • 2013
    Nat Genetics, Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Peifer M, Fernández-Cuesta L, Sos ML, George J, Seidel D, Kasper LH, Plenker D, Leenders F, Sun R, Zander T, Menon R, Koker M, Dahmen I, Müller C, Di Cerbo V, Schildhaus HU, Altmüller J, Baessmann I, Becker C, de Wilde B, Vandesompele J, Böhm D, Ansén S, Gabler F, Wilkening I, Heynck S, Heuckmann JM, Lu X, Carter SL, Cibulskis K, Banerji S, Getz G, Park KS, Rauh D, Grütter C, Fischer M, Pasqualucci L, Wright G, Wainer Z, Russell P, Petersen I, Chen Y, Stoelben E, Ludwig C, Schnabel P, Hoffmann H, Muley T, Brockmann M, Engel-Riedel W, Muscarella LA, Fazio VM, Groen H, Timens W, Sietsma H, Thunnissen E, Smit E, Heideman DA, Snijders PJ, Cappuzzo F, Ligorio C, Damiani S, Field J, Solberg S, Brustugun OT, Lund-Iversen M, Sänger J, Clement JH, Soltermann A, Moch H, Weder W, Solomon B, Soria JC, Validire P, Besse B, Brambilla E, Brambilla C, Lantuejoul S, Lorimier P, Schneider PM, Hallek M, Pao W, Meyerson M, Sage J, Shendure J, Schneider R, Büttner R, Wolf J, Nürnberg P, Perner S, Heukamp LC, Brindle PK, Haas S, Thomas RK. Nat Genet. 2012 Oct;44(10):1104-10. doi: 10.1038/ng.2396. Epub 2012 Sep 2.